JUDO BIO
Live / Allowed — Second extension granted (statement of use) (as of 19 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 14 Aug 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98697738
- Mark type
- Word mark
- Filed
- 14 Aug 2024
- Published for opposition
- 24 Jun 2025
- Attorney of record
- Holly A. Coldiron
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and therapeutic agents for the treatment of nephrological and systemic diseases, namely, inborn errors of metabolism, gout, hypertension, type 2 diabetes, chronic heart failure, nephrolithiasis, and endocrine disorders; Pharmaceutical preparations, namely, oligonucleotides, siRNA and antisense RNA (asRNA) for medical use and use in the treatment of nephrological and systemic diseases, namely, inborn errors of metabolism, gout, hypertension, type 2 diabetes, chronic heart failure, nephrolithiasis, and endocrine disorders
Owner
- Judo Bio, Inc., Cambridge, MA, US
- Judo Bio, Inc., Cambridge, MA, US
Prosecution history
- 20 Aug 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Aug 2026 — SOU EXTENSION 2 GRANTED
- 19 Aug 2026 — SOU EXTENSION 2 FILED
- 19 Aug 2026 — SOU TEAS EXTENSION RECEIVED
- 14 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Feb 2026 — SOU EXTENSION 1 GRANTED
- 13 Feb 2026 — SOU EXTENSION 1 FILED
- 13 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 19 Aug 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 24 Jun 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Jun 2025 — PUBLISHED FOR OPPOSITION
- 18 Jun 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 May 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 May 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 16 May 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE